Clinical Trials
🌏 NMPA Page 6NMPA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 61–72 of 75 articles
Hengrui Pharma Q1 2026 Results: Anti-PD-L1/TGF-βRII Fusion Protein Approved in China
NOVI Health's Hybrid Care Model Bridges GLP-1 Drug Efficacy Gap Between Clinical Trials and Real-World Outcomes
Suvoda Launches Agentic AI-Powered RTSM System, Reduces Clinical Trial Startup Time by 80%
Dayspring Pharma's CG2001 Foam Meets Primary Endpoint in Phase II Male Pattern Baldness Trial
PeptiDream Partner Asahi Kasei Therapeutics Initiates Phase 1 Clinical Trial for AK1940
Rznomics RZ-001 Shows 61.5% Response Rate in Hepatocellular Carcinoma Trial at AACR 2026
Biogen Acquires Felzartamab Rights from TJ Biopharma for Greater China Market
Argo Biopharma Begins Phase II Trials of BW-40202 siRNA Therapy for Rare Kidney Diseases
HSA Clinical Trial Modernization: Singapore's New Framework for CITDs
Zai Lab's ZL-1503 Bispecific Antibody Shows Promise for Rapid Itch Relief in Atopic Diseases
Phantom Neuro Receives Approval for First Human Trial of Phantom X Neural Interface System
XellSmart Advances XS411 Parkinson's Cell Therapy to Phase II Trial After Positive Phase I Results